Capricor Therapeutics, Inc. (CAPR)
5.93
-0.20
(-3.26%)
USD |
NASDAQ |
Oct 23, 16:00
5.95
+0.02
(+0.34%)
After-Hours: 20:00
Capricor Therapeutics Market Cap : 344.59M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 344.59M |
| October 22, 2026 | 356.21M |
| October 21, 2026 | 341.68M |
| October 20, 2026 | 384.10M |
| October 19, 2026 | 386.42M |
| October 16, 2026 | 389.91M |
| October 15, 2026 | 422.45M |
| October 14, 2026 | 382.94M |
| October 13, 2026 | 399.79M |
| October 12, 2026 | 434.07M |
| October 09, 2026 | 454.99M |
| October 08, 2026 | 465.45M |
| October 07, 2026 | 470.68M |
| October 06, 2026 | 450.34M |
| October 05, 2026 | 452.09M |
| October 02, 2026 | 520.08M |
| October 01, 2026 | 519.49M |
| September 30, 2026 | 550.29M |
| September 29, 2026 | 497.99M |
| September 28, 2026 | 506.13M |
| September 25, 2026 | 485.79M |
| September 24, 2026 | 497.99M |
| September 23, 2026 | 503.80M |
| September 22, 2026 | 542.74M |
| September 21, 2026 | 517.17M |
| Date | Value |
|---|---|
| September 18, 2026 | 526.47M |
| September 17, 2026 | 547.39M |
| September 16, 2026 | 497.41M |
| September 15, 2026 | 497.41M |
| September 14, 2026 | 511.94M |
| September 11, 2026 | 486.37M |
| September 10, 2026 | 482.30M |
| September 09, 2026 | 502.06M |
| September 08, 2026 | 526.47M |
| September 04, 2026 | 546.22M |
| September 03, 2026 | 539.25M |
| September 02, 2026 | 574.70M |
| September 01, 2026 | 581.67M |
| August 31, 2026 | 575.86M |
| August 28, 2026 | 557.27M |
| August 27, 2026 | 584.58M |
| August 26, 2026 | 543.90M |
| August 25, 2026 | 481.72M |
| August 24, 2026 | 395.14M |
| August 21, 2026 | 365.51M |
| August 20, 2026 | 397.18M |
| August 19, 2026 | 463.71M |
| August 18, 2026 | 411.41M |
| August 17, 2026 | 432.91M |
| August 14, 2026 | 386.42M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ARS Pharmaceuticals, Inc. | 400.73M |
| SELLAS Life Sciences Group, Inc. | 2.330B |
| Sionna Therapeutics, Inc. | 162.59M |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Cytokinetics, Inc. | 8.496B |
Market Cap Related Metrics
| PEG Ratio | -0.0491 |
| Price to Book Value | 1.400 |
| Price | 5.93 |
| Earnings Yield | -41.30% |
| PEGY Ratio | -0.0491 |